Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma-Reference-Cited by-同舟云学术

Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma

Published:2021-09 Issue: Volume:30 Page:38-42
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Khanolkar Rutvij A.,Quon Harvey,Thind Kundan,Sia Michael,Roumeliotis Michael,Husain Siraj,McGeachy Philip,Meyer Tyler,Martell Kevin

Funder

University of Calgary Faculty of Medicine

Alberta Cancer Foundation

University of Calgary

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference26 articles.

1. Canadian Cancer Statistics 2005;Canadian Cancer Society/National Cancer Institute of Canada;Can Cancer Soc,2005

2. Quon H, Loblaw A, Nam R. Dramatic increase in prostate cancer cases by 2021. BJU Int 2011;108:1734–8.

3. Roehrborn CG, Black LK. The economic burden of prostate cancer. BJU Int 2011;108:806–13.

4. Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events;Krahn;Curr Oncol,2014

5. Jemal A, Ma J, Siegel R, et al. Prostate cancer incidence rates 2 years after the US Preventive Services Task Force recommendations against screening. JAMA Oncol 2016;2:1657–60.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indications for additional volume studies for gland volume estimation in prostate cancer brachytherapy;Journal of Radiation Research;2022-08-23